ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1745

Amelioration of Experimental Autoimmune Arthritis by Adoptive Transfer of Foxp3-Expressing Regulatory B Cells Is Associated with the Regulatory T Cell/T helper 17 cell Balance

Young Ok Jung1, Yu Jung Heo2, Mi Kyung Park3, Mi-La Cho4, Seung Ki Kwok5, Ji Hyeon Ju2, Kyung Su PARK2, Sung Hwan PARK2, Ho Youn Kim2 and Jun-Ki Min6, 1Internal Medicine Hallym University Kangnam Sacred Heart Hospital, Seoul, South Korea, 2Catholic University, Seoul, South Korea, 3Rheumatism Research Center (RhRC), The Catholic University of Korea, Seoul, South Korea, 4Rheumatism Research Center, Catholic Research Institute of Medical Science, Catholic University of Korea, Seoul, South Korea, 5The Catholic University, Seoul, South Korea, 6Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: regulatory cells and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Foxp3 is a key regulator of the development and function of regulatory T cells (Tregs), and its expression is thought to be T cell-restricted. We hypothesized that B cells can express Foxp3 and B cells expressing Foxp3 may play a role in preventing the development of collagen-induced arthritis (CIA).

Methods: Protein and mRNA expression of Foxp3 in CD19+ B cells from mice was determined by flow cytometry, western blotting, and RT-PCR. Confocal microscopy was used to visualize the location and expression of Foxp3 in B and T cells. Foxp3 expression was modulated in CD19+ B cells by transfection with shRNA or using an over-expression construct. In vitro suppressive activity of Foxp3-expressing B cells on T cell proliferation was assessed by a 3H-thymidine incorporation assay. In addition, Foxp3-transfected B cells were adoptively transferred to CIA mice. Therapeutic effects were evaluated by clinical symptoms and joint histopathology.

Results: We found that lipopolysaccharide (LPS) or anti-IgM stimulation induced Foxp3 expression in B cells. Foxp3-expressing B cells were found in the spleens of mice. To generate Foxp3-expressing B cells in vitro, we transfected CD19+ B cells with a Foxp3 over-expression construct. Over-expression of Foxp3 conferred a contact-dependent suppressive ability on proliferation of responder T cells. Down-regulation of Foxp3 by shRNA caused a profound reduction in proliferation of responder T cells. Adoptive transfer of Foxp3+CD19+ B cells attenuated the clinical symptoms of CIA significantly with concomitant suppression of IL-17 production and enhancement of Foxp3 expression in CD4+ T cells from splenocytes.

Conclusion: Our data indicate that Foxp3 expression is not restricted to T cells. The expression of Foxp3 in B cells is critical for the immunoregu­lation of T cells and limits autoimmunity in a mouse model.


Disclosure:

Y. O. Jung,
None;

Y. J. Heo,
None;

M. K. Park,
None;

M. L. Cho,
None;

S. K. Kwok,
None;

J. H. Ju,
None;

K. S. PARK,
None;

S. H. PARK,
None;

H. Y. Kim,
None;

J. K. Min,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/amelioration-of-experimental-autoimmune-arthritis-by-adoptive-transfer-of-foxp3-expressing-regulatory-b-cells-is-associated-with-the-regulatory-t-cellt-helper-17-cell-balance/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology